ESTIMATING R0 OF SARS-COV-2 IN HEALTHCARE SETTINGS

Laura Temime, Marie-Paule Gustin, Audrey Duval, Niccolò Buetti, Pascal Crépey, Didier Guillemot, Rodolphe ThiéBaut, Philippe Vanhems, Jean-Ralph Zahar, David R.M. Smith, Lulla Opatowski
doi: https://doi.org/10.1101/2020.04.20.20072462

Article Information

doi 
https://doi.org/10.1101/2020.04.20.20072462
History 
  • April 24, 2020.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.

Author Information

  1. Laura Temime1,*,
  2. Marie-Paule Gustin2,
  3. Audrey Duval3,
  4. Niccolò Buetti4,
  5. Pascal Crépey5,
  6. Didier Guillemot6,
  7. Rodolphe ThiéBaut7,
  8. Philippe Vanhems8,
  9. Jean-Ralph Zahar9,
  10. David R.M. Smith10 and
  11. Lulla Opatowski11
  1. 1MESuRS laboratory, Conservatoire national des arts et métiers, Paris, France; PACRI Unit, Institut Pasteur, Conservatoire national des arts et métiers, Paris, France
  2. 2Institute of Pharmaceutic and Biological Sciences, University Claude Bernard Lyon 1, Villeurbanne, France; Emerging Pathogens Laboratory-Fondation Mérieux, International Center for Infectiology Research (CIRI), Inserm U1111, CNRS UMR5308, ENS de Lyon, Lyon, France
  3. 3Université Paris-Saclay, UVSQ, Univ. Paris-Sud, Inserm, CESP, Anti-infective evasion and pharmacoepidemiology team, Montigny-Le-Bretonneux, France; Institut Pasteur, Epidemiology and Modelling of Antibiotic Evasion unit, Paris, France
  4. 4INSERM IAME, U1137, Team DesCID, Paris, France
  5. 5UPRES-EA 7449 REPERES « Recherche en Pharmaco-Epidémiologie et Recours aux Soins » – EHESP – Université de Rennes, Rennes, France
  6. 6Université Paris-Saclay, UVSQ, Univ. Paris-Sud, Inserm, CESP, Anti-infective evasion and pharmacoepidemiology team, Montigny-Le-Bretonneux, France; Institut Pasteur, Epidemiology and Modelling of Antibiotic Evasion unit, Paris, France; AP-HP Paris Saclay, Public Health, Medical Information, Clinical research, Le Kremlin-Bicêtre, France
  7. 7INSERM U1219 Bordeaux Population Health, Université de Bordeaux, Bordeaux, France; INRIA SISTM team, Talence, France; Vaccine Research Institute, Créteil, France
  8. 8Emerging Pathogens Laboratory-Fondation Mérieux, International Center for Infectiology Research (CIRI), Inserm U1111, CNRS UMR5308, ENS de Lyon, Lyon, France; Service d’Hygiène, Epidémiologie et Prévention, Hospices Civils de Lyon, F-69437, Lyon, France; Inserm, F-CRIN, Réseau Innovative Clinical Research in Vaccinology (I-REIVAC), Paris, France
  9. 9IAME, UMR 1137, Université Paris 13, Sorbonne Paris Cité, France; Service de Microbiologie Clinique et Unité de Contrôle et de Prévention du Risque Infectieux, Groupe Hospitalier Paris Seine Saint-Denis, AP-HP, Bobigny, France
  10. 10Université Paris-Saclay, UVSQ, Univ. Paris-Sud, Inserm, CESP, Anti-infective evasion and pharmacoepidemiology team, Montigny-Le-Bretonneux, France; Institut Pasteur, Epidemiology and Modelling of Antibiotic Evasion unit, Paris, France; MESuRS laboratory, Conservatoire national des arts et métiers, Paris, France
  11. 11Université Paris-Saclay, UVSQ, Univ. Paris-Sud, Inserm, CESP, Anti-infective evasion and pharmacoepidemiology team, Montigny-Le-Bretonneux, France; Institut Pasteur, Epidemiology and Modelling of Antibiotic Evasion unit, Paris, France
  1. ↵*Corresponding author: Laura Temime, MESuRS laboratory, Conservatoire national des Arts et Métiers, 292 rue Saint-Martin – 75141 Paris Cedex 03, France, Email: laura.temime{at}lecnam.net
Back to top
Posted April 24, 2020.
Download PDF
Data/Code
Email
ESTIMATING R0 OF SARS-COV-2 IN HEALTHCARE SETTINGS
Laura Temime, Marie-Paule Gustin, Audrey Duval, Niccolò Buetti, Pascal Crépey, Didier Guillemot, Rodolphe ThiéBaut, Philippe Vanhems, Jean-Ralph Zahar, David R.M. Smith, Lulla Opatowski
medRxiv 2020.04.20.20072462; doi: https://doi.org/10.1101/2020.04.20.20072462
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area